EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chronic infection and metabolic stress: a converging axis driving hypertension and metabolic dysfunction-associated steatotic liver disease outcomes

Jannis Kountouras iD, Stergios A Polyzos iD, Elisabeth Vardaka iD, Christos Zavos iD, Michael Doulberis iD

American Journal of Hypertension · 01.09.2026 · 39 (9) · 1045-1054

DOI: 10.1093/ajh/hpag064 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Hypertension, online erschienen am 22.06.2026. Verfasst von Jannis Kountouras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece. Hauptthemen laut MEDLINE: Hypertension, Helicobacter Infections, Stress, Physiological, Fatty Liver. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a systemic cardiometabolic disorder arising from the convergence of metabolic stress, chronic low-grade (smoldering) inflammation, and vascular pathology. MASLD extends beyond hepatic fat accumulation, and is tightly linked to arterial hypertension and cardiovascular disease, with arterial hypertension acting as a disease modifier that accelerates fibrosis progression and deteriorates long-term outcomes. Emerging evidence suggests that chronic infections, particularly Helicobacter pylori infection, may further amplify this cardiometabolic continuum by sustaining inflammatory signaling, oxidative stress, insulin resistance, and endothelial damage. These mechanisms substantially overlap with crucial pathogenic pathways implicated in MASLD progression and hypertension onset. At the molecular level, AMP-activated protein kinase (AMPK) signaling represents a key integrative axis linking energy homeostasis, inflammation, and blood pressure regulation. Pharmacological AMPK activation, exemplified by imeglimin targeting presenilin enhancer-2, highlights the translational potential of therapies addressing hepatic and vascular injury simultaneously. This perspective summarizes clinical and mechanistic evidence supporting an integrated, systems-based framework in which chronic infection and metabolic stress converge along a shared axis to drive hypertension and MASLD. It underscores the need to incorporate metabolic regulation, cardiovascular risk modification, and selected infectious determinants into future risk stratification models and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHelicobacter InfectionsStress, PhysiologicalFatty LiverNon-alcoholic Fatty Liver DiseaseHumansAnimalsAMP-Activated Protein KinasesChronic DiseaseSignal TransductionOxidative StressHelicobacter pylori

Stichwörter der Autor:innen

Helicobacter pyloriAMPK signalingMASLDarterial hypertensionblood pressurechronic infectionhypertensionmetabolic stress

Substanzen

AMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece.
  • First Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.
  • Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Thessaloniki, Greece.
  • Department of Gastroenterology & Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland.

ORCID-Profile: Jannis Kountouras, Stergios A Polyzos, Elisabeth Vardaka, Christos Zavos, Michael Doulberis

Zitieren

APA

Kountouras, J., Polyzos, S. A., Vardaka, E., Zavos, C., & Doulberis, M. (2026). Chronic infection and metabolic stress: a converging axis driving hypertension and metabolic dysfunction-associated steatotic liver disease outcomes. American Journal of Hypertension, 39(9), 1045-1054. https://doi.org/10.1093/ajh/hpag064

Vancouver

Kountouras J, Polyzos SA, Vardaka E, Zavos C, Doulberis M. Chronic infection and metabolic stress: a converging axis driving hypertension and metabolic dysfunction-associated steatotic liver disease outcomes. American Journal of Hypertension. 2026;39(9):1045-1054. doi:10.1093/ajh/hpag064

BibTeX
@article{Kountouras2026,
  author = {Kountouras, Jannis and Polyzos, Stergios A and Vardaka, Elisabeth and Zavos, Christos and Doulberis, Michael},
  title = {Chronic infection and metabolic stress: a converging axis driving hypertension and metabolic dysfunction-associated steatotic liver disease outcomes},
  journal = {American Journal of Hypertension},
  year = {2026},
  volume = {39},
  number = {9},
  pages = {1045--1054},
  doi = {10.1093/ajh/hpag064}
}
Kostenlos starten →